Penumbra, Inc.

NYSE:PEN

Medical - Devices

Healthcare
$320.60 -0.72%

-$2.30 today

Market cap
$12.64B
Beta
0.70
P/E (TTM)
72.6
EPS (TTM)
$4.36
52W Low $221.26High $362.41

Volume 0.21M

Average 0.50M

PEN Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Penumbra, Inc.NYSE: PEN

Gross Profit · Q2 FY2026 · quarter ended Jun 2026

Gross profit grows in line with its trailing trend

Q2 FY2026 gross profit of $264.94M rose 18.3% year over year, behind the +20.0% change in trailing-twelve-month gross profit. Sequentially, it rose 4.6% from the prior quarter. Over 3 fiscal years it compounded at +20.8% a year.

Context

  • Gross profit amounted to 67.1% of revenue in FY2025, up 3.9 pp from a year earlier.
  • Gross profit increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +18.3% toward the trailing-twelve-month pace of +20.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$264.94M+4.6% QoQ
Last fiscal yearDec 2025
$942.44M+24.8% YoY
LTMJun 2026
$1.02B+20.0% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+18.3%——
1 year+24.8%——
3-year CAGR+20.8%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
942.44M USD
Year-over-year change
+24.8%
4-year CAGR
+18.7%

Gross Profit vs competitors

How PEN compares with its peers on the latest reported figures

  • PEN's LTM Jun 2026 gross profit of $1.02B is the 6th highest of the 9 companies compared; the peer median is $6.43B.
  • Its year-over-year change of +20.0% is the 3rd highest of 9, against a peer median of +15.9%.
  • Gross profit amounts to 67.8% of revenue for PEN, versus a peer median of 66.9%.
PEN Competitors Peer median
Gross Profit for PEN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ABTAbbott LaboratoriesLTM Sep 2026$27.55B +16.4%+3.3%57.1%
MDTMedtronic plcLTM Jul 2026$25.04B +15.4%+4.9%66.7%
BSXBoston Scientific CorporationLTM Jun 2026$14.94B +27.8%+21.5%71.2%
ISRGIntuitive Surgical, Inc.LTM Sep 2026$7.78B +21.9%+16.5%67.2%
EWEdwards Lifesciences CorporationLTM Jun 2026$5.08B +13.2%+4.0%78.0%
PENPenumbra, Inc.LTM Jun 2026$1.02B +20.0%+20.8%67.8%
MMSIMerit Medical Systems, Inc.LTM Sep 2026$796.04M +11.3%+12.4%49.4%
LMATLeMaitre Vascular, Inc.LTM Mar 2026$185.52M +19.2%+19.4%72.4%
ANGOAngioDynamics, Inc.LTM Feb 2026$167.69M +8.9%-1.6%53.5%
Peer median (excluding PEN) $6.43B+15.9%+8.6%66.9%

Competitors are the stored peer set for PEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue747.59M847.13M1.06B1.19B1.4B
Cost of Revenue272.21M311.93M375.88M439.62M461.23M
Gross Profit475.38M535.21M682.64M755M942.44M
Gross Margin63.6%63.2%64.5%63.2%67.1%
Research & Development104.55M79.41M84.42M94.78M89.77M
Selling, General & Admin378.33M449.72M506.45M573.99M663.42M
Operating Expenses482.88M529.13M609.09M668.77M753.19M
Depreciation & Amortization16.41M24.32M27.26M23.7M17.47M
EBITDA7.84M29.96M108.65M45.99M223.91M
EBITDA Margin1.0%3.5%10.3%3.8%16.0%
Operating Income(7.5M)6.08M73.55M86.22M189.25M
Operating Margin-1.0%0.7%6.9%7.2%13.5%
Interest Income2.87M1.89M6.83M13.69M16.29M
Interest Expense1.93M1.75M1.74M1.42M1.31M
Other Income / Expenses(3M)(2.19M)6.1M(65.36M)15.88M
Income Before Tax(10.5M)3.89M79.65M20.87M205.13M
Pre-Tax Margin-1.4%0.5%7.5%1.7%14.6%
Income Tax Expense(13.13M)5.89M(11.3M)6.86M27.44M
Net Income5.28M(2M)90.95M14.01M177.69M
Net Margin0.7%-0.2%8.6%1.2%12.7%
EPS (Basic)0.14(0.05)2.370.364.57
EPS (Diluted)0.14(0.05)2.320.364.52
Weighted Avg Shares36.76M37.84M38.4M38.63M38.92M
Weighted Avg Shares (Diluted)37.88M37.84M39.22M39.27M39.29M

Penumbra, Inc.

NYSE:PEN

Intrinsic Alpha fair value

Locked

Current Price

$320.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.